Tofacitinib Appears Well Tolerated and Effective for the Treatment of Patients with Refractory Crohn’s Disease
Scott D. Lee, Anand Singla, Jason Harper, Mitra Barahimi, Jeffrey Jacobs, Kendra Kamp, Kindra Clark‐Snustad
Topics & Concepts
MedicineAdverse effectCrohn's diseaseInternal medicineHepatologyRefractory (planetary science)TofacitinibSurgeryGastroenterologyDiseaseRheumatoid arthritisPhysicsAstrobiologyInflammatory Bowel DiseaseAutoimmune and Inflammatory DisordersHidradenitis Suppurativa and Treatments